55 related articles for article (PubMed ID: 9202251)
1. Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy.
Yamate T; Mocharla H; Taguchi Y; Igietseme JU; Manolagas SC; Abe E
Endocrinology; 1997 Jul; 138(7):3047-55. PubMed ID: 9202251
[TBL] [Abstract][Full Text] [Related]
2. The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis.
Kovacić N; Lukić IK; Grcević D; Katavić V; Croucher P; Marusić A
J Immunol; 2007 Mar; 178(6):3379-89. PubMed ID: 17339432
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.
Chellaiah MA; Kizer N; Biswas R; Alvarez U; Strauss-Schoenberger J; Rifas L; Rittling SR; Denhardt DT; Hruska KA
Mol Biol Cell; 2003 Jan; 14(1):173-89. PubMed ID: 12529435
[TBL] [Abstract][Full Text] [Related]
4. Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia.
Kawaguchi H; Manabe N; Miyaura C; Chikuda H; Nakamura K; Kuro-o M
J Clin Invest; 1999 Aug; 104(3):229-37. PubMed ID: 10430604
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol.
Di Gregorio GB; Yamamoto M; Ali AA; Abe E; Roberson P; Manolagas SC; Jilka RL
J Clin Invest; 2001 Apr; 107(7):803-12. PubMed ID: 11285299
[TBL] [Abstract][Full Text] [Related]
6. Increased osteoclastogenesis in mice lacking the carcinoembryonic antigen-related cell adhesion molecule 1.
Heckt T; Bickert T; Jeschke A; Seitz S; Schulze J; Ito WD; Zimmermann W; Amling M; Schinke T; Horst AK; Keller J
PLoS One; 2014; 9(12):e114360. PubMed ID: 25490771
[TBL] [Abstract][Full Text] [Related]
7. Elimination of senescent osteoclast progenitors has no effect on the age-associated loss of bone mass in mice.
Kim HN; Chang J; Iyer S; Han L; Campisi J; Manolagas SC; Zhou D; Almeida M
Aging Cell; 2019 Jun; 18(3):e12923. PubMed ID: 30773784
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocytes Enhance Mesenchymal Stromal Cells Proliferation and Inhibit Differentiation.
Emmakah AM; Arman HE; Alvarez MB; Childress PJ; Bidwell JP; Goebel WS; Gabriel Chu TM; Kacena MA
J Cell Biochem; 2017 Jul; ():. PubMed ID: 28722829
[TBL] [Abstract][Full Text] [Related]
9. Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease.
Gerov V; Gerova D; Micheva I; Nikolova M; Pasheva M; Nazifova N; Galunska B
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067265
[TBL] [Abstract][Full Text] [Related]
10. Development of artificial bone graft via
Ma C; Tao C; Zhang Z; Zhou H; Fan C; Wang DA
Mater Today Bio; 2023 Dec; 23():100893. PubMed ID: 38161510
[TBL] [Abstract][Full Text] [Related]
11. Giant Cells of Various Lesions Are Characterised by Different Expression Patterns of HLA-Molecules and Molecules Involved in the Cell Cycle, Bone Metabolism, and Lineage Affiliation: An Immunohistochemical Study with a Review of the Literature.
Hild V; Mellert K; Möller P; Barth TFE
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509363
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Osteopontin and Bone Mineral Density.
Vancea A; Serban O; Fodor D
Acta Endocrinol (Buchar); 2021; 17(4):509-516. PubMed ID: 35747863
[TBL] [Abstract][Full Text] [Related]
13. Bone Defect Repair Using a Bone Substitute Supported by Mesenchymal Stem Cells Derived from the Umbilical Cord.
Kosinski M; Figiel-Dabrowska A; Lech W; Wieprzowski L; Strzalkowski R; Strzemecki D; Cheda L; Lenart J; Domanska-Janik K; Sarnowska A
Stem Cells Int; 2020; 2020():1321283. PubMed ID: 32300364
[TBL] [Abstract][Full Text] [Related]
14. Ganoderma lucidum, a promising agent possessing antioxidant and anti-inflammatory effects for treating calvarial defects with graft application in rats.
Laçin N; İzol SB; İpek F; Tuncer MC
Acta Cir Bras; 2019; 34(9):e201900904. PubMed ID: 31778526
[TBL] [Abstract][Full Text] [Related]
15. Short-term use of resveratrol in alloplastic graft material applied with calvarial bone defects in rats.
Laçin N; Deveci E
Acta Cir Bras; 2019 Sep; 34(7):e201900704. PubMed ID: 31531539
[TBL] [Abstract][Full Text] [Related]
16. The effect of graft application and allopurinol treatment on calvarial bone defect in rats1.
Laçin N; İzol BS; Özkorkmaz EG; Deveci B; Tuncer MC
Acta Cir Bras; 2019 Mar; 34(3):e201900306. PubMed ID: 30892392
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells: key players in cancer progression.
Ridge SM; Sullivan FJ; Glynn SA
Mol Cancer; 2017 Feb; 16(1):31. PubMed ID: 28148268
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-induced premature osteoblast-to-preosteocyte transitioning has multiple effects on calvarial development.
Jeradi S; Hammerschmidt M
Development; 2016 Apr; 143(7):1205-16. PubMed ID: 26903503
[TBL] [Abstract][Full Text] [Related]
19. Matricellular proteins as regulators of cancer metastasis to bone.
Trotter TN; Yang Y
Matrix Biol; 2016; 52-54():301-314. PubMed ID: 26807761
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer and bone: the elective affinities.
Rucci N; Angelucci A
Biomed Res Int; 2014; 2014():167035. PubMed ID: 24971315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
